Immunome
(NASDAQ) IMNM
Immunome Financials at a Glance
Market Cap
$2.47B
Revenue (TTM)
$6.94M
Net Income (TTM)
$212.39M
EPS (TTM)
$-2.43
P/E Ratio
-9.01
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$23.01
Volume
16,606
Open
$22.26
Price
$23.01
Volume
16,606
Open
$22.26
Previous Close
$21.87
Daily Range
$22.20 - $23.11
52-Week Range
$5.15 - $27.65
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$23.01
Volume
16,606
Open
$22.26
Previous Close
$21.87
Daily Range
$22.20 - $23.11
52-Week Range
$5.15 - $27.65
IMNM News
IMNM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immunome
Industry
Biotechnology
Sector
Health CareEmployees
177
CEO
Clay B. Siegall, PhD
Website
www.immunome.comHeadquarters
Bothell, PA 19341, US
IMNM Financials
Key Financial Metrics (TTM)
Gross Margin
-6%
Operating Margin
-31%
Net Income Margin
-31%
Return on Equity
-52%
Return on Capital
-34%
Return on Assets
-31%
Earnings Yield
-11.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.47B
Shares Outstanding
113.13M
Volume
16.61K
Short Interest
0.00%
Avg. Volume
1.59M
Financials (TTM)
Gross Profit
$3.99M
Operating Income
$214.11M
EBITDA
$211.16M
Operating Cash Flow
$190.92M
Capital Expenditure
$9.69M
Free Cash Flow
$200.60M
Cash & ST Invst.
$653.48M
Total Debt
$3.85M
Immunome Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$776.00K
-128.3%
Gross Margin
0.00%
N/A
Market Cap
$2.47B
N/A
Market Cap/Employee
$18.89M
N/A
Employees
131
N/A
Net Income
$69.90M
+12.9%
EBITDA
$62.09M
-12.9%
Quarterly Fundamentals
Net Cash
$649.63M
+205.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.85M
-19.2%
Short Term Debt
$0.00
-100.0%
Return on Assets
-31.09%
N/A
Return on Invested Capital
-33.55%
N/A
Free Cash Flow
$51.95M
-19.6%
Operating Cash Flow
$47.95M
-14.0%